Literature DB >> 7044294

Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.

V M Millet, M Dreisbach, Y J Bryson.   

Abstract

A total of 52 healthy, adult volunteers were randomly assigned to five treatment groups to be treated twice daily for 4 days with 100 mg of amantadine, 100 mg of rimantadine, 4 mg of chlorpheniramine or placebo alone, or 100 mg of amantadine in combination with chlorpheniramine. The results of tests measuring performance on tasks of attention, reasoning, and memory were unaffected by treatment. Subjective side effects in recipients of amantadine, rimantadine, and chlorpheniramine were comparable and minimal. Side effects appeared to be enhanced in subjects receiving both amantadine and chlorpheniramine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044294      PMCID: PMC181819          DOI: 10.1128/AAC.21.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Prevention and control of influenza by chemoprophylaxis and chemotherapy. Prospects from examination of recent experience.

Authors:  G G Jackson; E D Stanley
Journal:  JAMA       Date:  1976-06-21       Impact factor: 56.272

2.  From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus.

Authors:  J R LaMontagne; G J Galasso
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

3.  Evaluation of amantadine in artificially induced A2 and B influenza.

Authors:  A A Smorodintsev; D M Zlydnikov; A M Kiseleva; J A Romanov; A P Kazantsev; V I Rumovsky
Journal:  JAMA       Date:  1970-08-31       Impact factor: 56.272

4.  The effect of marihuana on tracking task performance.

Authors:  W T Roth; J R Tinklenberg; C A Whitaker; C F Darley; B S Kopell; L E Hollister
Journal:  Psychopharmacologia       Date:  1973

5.  Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

Authors:  W L Wingfield; D Pollack; R R Grunert
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

6.  Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak.

Authors:  S Rabinovich; J T Baldini; R Bannister
Journal:  Am J Med Sci       Date:  1969-05       Impact factor: 2.378

7.  Amantadine intoxication reversed by physostigmine.

Authors:  D E Casey
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

8.  A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis.

Authors:  Y J Bryson; C Monahan; M Pollack; W D Shields
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  A component analysis of attentional problems of educationally handicapped boys.

Authors:  B K Keogh; J S Margolis
Journal:  J Abnorm Child Psychol       Date:  1976

10.  Prevention of Russian influenza by amantadine.

Authors:  A S Monto; R A Gunn; M G Bandyk; C L King
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

View more
  10 in total

Review 1.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

Review 3.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

4.  Amantadine for adynamic speech: possible benefit for aphasia?

Authors:  Anna M Barrett; Paul J Eslinger
Journal:  Am J Phys Med Rehabil       Date:  2007-08       Impact factor: 2.159

Review 5.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

Review 6.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

Review 7.  The future of antiviral chemotherapy.

Authors:  S Crowe; J Mills
Journal:  Dermatol Clin       Date:  1988-10       Impact factor: 3.478

8.  Chapter 12. Antiviral Agents.

Authors:  James L Kelley
Journal:  Annu Rep Med Chem       Date:  2008-04-10       Impact factor: 1.059

9.  Chapter 7 Orthomyxovirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

Review 10.  Antiviral agents.

Authors:  E D Reines; P A Gross
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.